Oral GLP-1 Orforglipron (Foundayo) Achieves Weight Loss for Women of All Ages
Healthline · 2h ago
Eli Lilly
Medicine & Biotech · covered by 11 outlets this week · tracked since 2026-10-27
Press: 2 mainstream 7 specialist 3 independent outlet-days
Coverage
FDA Approves Lilly’s New Oral Combo Pill for Common Breast Cancer Mutation
Healthline · 2h ago
Bid to Block GLP-1 Ads Denied; First Weekly Insulin for T2D in Kids; Fertility Fell
MedPage Today · 7h ago
Court rejects Novo bid to block Lilly obesity drug ads
BioPharma Dive · 9h ago
study
STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
STAT Biotech · 11h ago
Judge backs Lilly in Novo lawsuit over weight-loss drug ads
Pharmaphorum · 16h ago
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
STAT Health Tech · 5d ago
Weight-loss drugs show signs of slowing biological aging, say drugmakers
MIT Technology Review Biotech · 21d ago
Lilly’s twin bets reshape diabetes weight loss
Longevity.Technology · 22d ago
‘It’s problematic’: concern as weight-loss jab maker sponsors Vogue World event
Guardian Health & Wellbeing (Life & Style) · 30d ago
GLP-1 pill market fuels manufacturing race between Eli Lilly and Novo Nordisk
Pharma Manufacturing · 32d ago
NewLimit raises $435M led by Founders Fund to bring longevity medicines to human trials
NewLimit blog · 147d ago
